308430 Stock Chart & Stats
₩10620.00
-₩970.00(-8.37%)
―
--
Day’s Range― - ―
52-Week Range₩9,930.00 - ₩42,200.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)33.94K
Market Cap
₩149.57B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding12,905,251
10 Day Avg. Volume27,546
30 Day Avg. Volume33,936
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,632,892.8
Revenue Forecast (FY)₩58.88T
308430 FAQ
What was Cellbion Co., Ltd’s price range in the past 12 months?
Cellbion Co., Ltd lowest stock price was ₩9930.00 and its highest was ₩42200.00 in the past 12 months.
What is Cellbion Co., Ltd’s market cap?
Cellbion Co., Ltd’s market cap is ₩149.57B.
When is Cellbion Co., Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cellbion Co., Ltd’s earnings last quarter?
Cellbion Co., Ltd released its earnings results on May 14, 2026. The company reported -₩186.872 earnings per share for the quarter, missing the consensus estimate of N/A by -₩186.872.
Is Cellbion Co., Ltd overvalued?
According to Wall Street analysts Cellbion Co., Ltd’s price is currently Undervalued.
Does Cellbion Co., Ltd pay dividends?
Cellbion Co., Ltd does not currently pay dividends.
What is Cellbion Co., Ltd’s EPS estimate?
Cellbion Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cellbion Co., Ltd have?
Cellbion Co., Ltd has 12,905,251 shares outstanding.
What happened to Cellbion Co., Ltd’s price movement after its last earnings report?
Cellbion Co., Ltd reported an EPS of -₩186.872 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.181%.
Which hedge fund is a major shareholder of Cellbion Co., Ltd?
Currently, no hedge funds are holding shares in KR:308430
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bioneer Corporation
―
Anterogen Co., Ltd.
―
NKGen Biotech Korea Co., Ltd.
―
Genome & Co.
―
3billion, Inc.
―